ahlam1399
09-19-2016, 11:32 AM
**vartis intensifies Entresto push with new analysis
ZURICH (Reuters) - **vartis on Monday intensified its bid to convince doctors to prescribe its heart failure drug Entresto, releasing an analysis that concluded the medicine contributed to higher quality of life scores compared with an older drug.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=XIm5YIs57Ck:dhWIQlbi5t0:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=XIm5YIs57Ck:dhWIQlbi5t0:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=XIm5YIs57Ck:dhWIQlbi5t0:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=XIm5YIs57Ck:dhWIQlbi5t0:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=XIm5YIs57Ck:dhWIQlbi5t0:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/XIm5YIs57Ck
ZURICH (Reuters) - **vartis on Monday intensified its bid to convince doctors to prescribe its heart failure drug Entresto, releasing an analysis that concluded the medicine contributed to higher quality of life scores compared with an older drug.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=XIm5YIs57Ck:dhWIQlbi5t0:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=XIm5YIs57Ck:dhWIQlbi5t0:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=XIm5YIs57Ck:dhWIQlbi5t0:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=XIm5YIs57Ck:dhWIQlbi5t0:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=XIm5YIs57Ck:dhWIQlbi5t0:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/XIm5YIs57Ck